Indian American psychiatrist told to pay 145,000 USD for opiod violations

Published On 2020-05-01 04:15 GMT   |   Update On 2020-05-01 04:16 GMT

New York: An Indian American psychiatrist is paying $145,000 in fines over charges of over-prescribing opioid medications, according to the Justice Department. Prakash Bhatia, who practised pain control medicine in the San Diego area in California, agreed to pay the fine after the Drug Enforcement Agency began an investigation into whether he improperly prescribed opioids in violation of...

Login or Register to read the full article

New York: An Indian American psychiatrist is paying $145,000 in fines over charges of over-prescribing opioid medications, according to the Justice Department.

Prakash Bhatia, who practised pain control medicine in the San Diego area in California, agreed to pay the fine after the Drug Enforcement Agency began an investigation into whether he improperly prescribed opioids in violation of the Controlled Substances Act, the department said on Thursday.

"Overprescribing opioids to patients who need treatment for their pain has contributed to the opioid epidemic in this country," said Robert Brewer, the federal prosecutor for Southern California.

The US facing an epidemic of drug abuse from the illegal use of pain control medicines, which should be available only with only doctors' presccription.

Nearly 15,000 people died due to overdosing from prescription medicines in 2018, according to government statistics.

Prosecutors said that between March 2013 and December 2017, Bhatia wrote opioid prescriptions for medicines like hydromorphone, morphine, methadone, oxycodone, fentanyl and oxymorphone "without a legitimate medical purpose and/or outside the usual course of his professional practice."

He prescribed these medicines in combination with depressant medications like benzodiazepines and muscle relaxants, which are known to increase the risk of abuse, addiction and overdose, prosecutors said.

By Arul Louis for ians

Tags:    
Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Disclaimer :- This story, apart from the heading, has not been edited by Medical Dialogues Team and is auto-generated from news agency feeds. Source: IANS

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News